Cargando…
Dendritic Cell-Based Vaccination in Cancer: Therapeutic Implications Emerging from Murine Models
Dendritic cells (DCs) play a pivotal role in the orchestration of immune responses, and are thus key targets in cancer vaccine design. Since the 2010 FDA approval of the first cancer DC-based vaccine (Sipuleucel-T), there has been a surge of interest in exploiting these cells as a therapeutic option...
Autores principales: | Mac Keon, Soledad, Ruiz, María Sol, Gazzaniga, Silvina, Wainstok, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438595/ https://www.ncbi.nlm.nih.gov/pubmed/26042126 http://dx.doi.org/10.3389/fimmu.2015.00243 |
Ejemplares similares
-
Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model
por: Keon, Soledad Mac, et al.
Publicado: (2019) -
An Emerging Role for SNARE Proteins in Dendritic Cell Function
por: Collins, Laura E., et al.
Publicado: (2015) -
Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance
por: Nagy, Noémi Anna, et al.
Publicado: (2021) -
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
por: Repáraz, David, et al.
Publicado: (2022) -
Novel Murine Dendritic Cell Lines: A Powerful Auxiliary Tool for Dendritic Cell Research
por: Fuertes Marraco, Silvia A., et al.
Publicado: (2012)